Evidence map›Paper›PMID 39768247›Full record

ArticleLife (Basel, Switzerland)2024

Assessing the Comparative Efficacy of Sentinel Lymph Node Detection Techniques in Vulvar Cancer: Protocol for a Systematic Review and Meta-Analysis.

Balázs Vida, Balázs Lintner, Szabolcs Várbíró, Petra Merkely, Lotti Lúcia Lőczi, Nándor Ács, Richárd Tóth, Márton Keszthelyi

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Balázs VidaDepartment of Obstetrics and Gynecology, Semmelweis University, 1082 Budapest, Hungary.
Balázs LintnerDepartment of Obstetrics and Gynecology, Semmelweis University, 1082 Budapest, Hungary.
Szabolcs VárbíróWorkgroup of Research Management, Doctoral School, Semmelweis University, 1085 Budapest, Hungary.
Petra MerkelyDepartment of Obstetrics and Gynecology, Semmelweis University, 1082 Budapest, Hungary.
Lotti Lúcia LőcziDepartment of Obstetrics and Gynecology, Semmelweis University, 1082 Budapest, Hungary.
Nándor ÁcsDepartment of Obstetrics and Gynecology, Semmelweis University, 1082 Budapest, Hungary.
Richárd TóthDepartment of Obstetrics and Gynecology, Semmelweis University, 1082 Budapest, Hungary.ORCID 0009-0000-9535-5821
Márton KeszthelyiDepartment of Obstetrics and Gynecology, Semmelweis University, 1082 Budapest, Hungary.ORCID 0000-0003-4886-3481

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This systematic review and meta-analysis protocol aims to evaluate the comparative efficacy of different sentinel lymph node (SLN) detection techniques in the management of vulvar cancer. Vulvar cancer, though rare, predominantly affects older women and requires effective management strategies. The SLN technique has become a standard approach for early-stage cases, offering reduced morbidity compared to complete lymphadenectomy. Currently, various SLN detection methods exist, including the use of Technetium-99m (Tc99m), Indocyanine Green (ICG), and superparamagnetic iron oxide (SPIO), but there is a lack of comprehensive comparison of their efficacy. This review will systematically search relevant databases, including PubMed, Scopus, Cochrane, Web of Science and Embase following PRISMA guidelines, to gather data from clinical trials. The primary outcome will be the detection rates of SLN techniques with secondary outcomes examining patient characteristics and procedural factors. The analysis will utilize random-effects models to compare detection rates across studies. The results of this study aim to provide insights into the optimal SLN detection method with potential implications for clinical practice guidelines in vulvar cancer management. The protocol is registered under the PROSPERO registration number CRD42024590774.

Indexed as

Indocyanine greensentinel lymph nodeTechnetium-99mvulvar cancer

Identifiers

PMID39768247
PMCPMC11677005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.